Drug Design by Pharmacophore and Virtual Screening Approach

Pharmaceuticals (Basel). 2022 May 23;15(5):646. doi: 10.3390/ph15050646.

Abstract

Computer-aided drug discovery techniques reduce the time and the costs needed to develop novel drugs. Their relevance becomes more and more evident with the needs due to health emergencies as well as to the diffusion of personalized medicine. Pharmacophore approaches represent one of the most interesting tools developed, by defining the molecular functional features needed for the binding of a molecule to a given receptor, and then directing the virtual screening of large collections of compounds for the selection of optimal candidates. Computational tools to create the pharmacophore model and to perform virtual screening are available and generated successful studies. This article describes the procedure of pharmacophore modelling followed by virtual screening, the most used software, possible limitations of the approach, and some applications reported in the literature.

Keywords: bioinformatics; computational biology; drug discovery; ligand-based pharmacophore modeling; structure-based pharmacophore modeling; virtual screening.

Publication types

  • Review

Grants and funding

This research received no external funding. DG is supported by a post-doc fellowship under the project framework “CIR01_00017-“CNRBiOmics–Centro Nazionale di Ricerca in Bioinformatica per le Scienze “Omiche”–Rafforzamento del capitale umano” funded by MUR, CUP B56J20000960001.